NCT06516198 Auricular Acupressure in Prehabilitation
| NCT ID | NCT06516198 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-21 |
| Primary Completion | 2027-06-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-07-21 with a primary completion date of 2027-06-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Complementary medicine is recognized for its ability to enhance appetite, increase energy, reduce anxiety, decrease pain, and improve sleep, among many other benefits. Acupuncture is among the most frequent types of complementary medicine practiced in the US, and Medicare currently includes back pain as a reimbursable indication for this therapy. Acupuncture-related therapies may enhance efforts at prehabilitation in candidates for major lung resection.
Eligibility Criteria
Inclusion Criteria * Being considered for major lung surgery * Surgery is not scheduled for at least 2 weeks * Age ≥ 50 years * Able to understand English at a 4th grade level * No known contraindications to prehabilitation (strength, endurance, balance exercises) * Able to provide informed consent for participation * Has an adult care partner who will be available and capable of placing seeds * Has access to smart phone for communication and image sharing * Underwent frailty screening (given any score) * Able to perform spirometry testing in clinic Exclusion Criteria: * Allergy to Vaccaria seeds * Medical condition affecting either ear preventing use of auricular acupressure such as eczema, frostbite, sunburn
Contact & Investigator
Maria Lucia Madariaga, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT06516198 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Frailty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06516198 currently recruiting?
Yes, NCT06516198 is actively recruiting participants. Contact the research team at mlmadariaga@bsd.uchicago.edu for enrollment information.
Where is the NCT06516198 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06516198 clinical trial?
NCT06516198 is sponsored by University of Chicago. The principal investigator is Maria Lucia Madariaga, MD at University of Chicago. The trial plans to enroll 40 participants.